Eph receptor function is modulated by heterooligomerization of A and B type Eph receptors

Journal of Cell Biology

Volumn 195, Issue 6, 2011, Pages 1033-1045

  Janes, Peter W ^a   Griesshaber, Bettina ^a   Atapattu, Lakmali ^a   Nievergall, Eva ^a   Hii, Linda L ^a   Mensinga, Anneloes ^a,e   Chheang, Chanly ^a   Day, Bryan W ^b   Boyd, Andrew W ^b   Bastiaens, Philippe I ^c   Jørgensen, Claus ^d,f   Pawson, Tony ^d   Lackmann, Martin ^a  

^a MONASH UNIVERSITY   (Australia)

^b ROYAL BRISBANE AND WOMEN'S HOSPITAL   (Australia)

^c MAX PLANCK INSTITUTE OF MOLECULAR PHYSIOLOGY   (Germany)

^d MOUNT SINAI HOSPITAL   (Canada)

^e UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^f INSTITUTE OF CANCER RESEARCH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EPHRIN; EPHRIN RECEPTOR; EPHRIN RECEPTOR A2; EPHRIN RECEPTOR A3; EPHRIN RECEPTOR A5; EPHRIN RECEPTOR B2;

ANIMAL CELL; ARTICLE; CELL DIVISION; CELL STRAIN HEK293; CONTROLLED STUDY; CROSS REACTION; EXTRACELLULAR SPACE; GENE CLUSTER; GENE MUTATION; GLIOMA; HUMAN; HUMAN CELL; HUMAN TISSUE; MOLECULAR WEIGHT; NONHUMAN; OLIGOMERIZATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION; SITE DIRECTED MUTAGENESIS; TUMOR CELL;

ANIMALS; CELL LINE, TUMOR; CERCOPITHECUS AETHIOPS; COS CELLS; GLIOMA; HEK293 CELLS; HUMANS; MALE; POLYMERIZATION; PROSTATIC NEOPLASMS; RECEPTORS, EPH FAMILY; SIGNAL TRANSDUCTION;

EID: 84855494260     PISSN: 00219525     EISSN: 15408140     Source Type: Journal    
DOI: 10.1083/jcb.201104037     Document Type: Article

References (65)

1. Alonso-C, L.M., E.M. Trinidad, B. de Garcillan, M. Ballesteros, M. Castellanos, I. Cotillo, J.J. Muñoz, and A.G. Zapata. 2009. Expression profile of Eph receptors and ephrin ligands in healthy human B lymphocytes and chronic lymphocytic leukemia B-cells. Leuk. Res. 33:395-406. http://dx.doi.org/10.1016/j.leukres.2008.08.010
2. Astin, J.W., J. Batson, S. Kadir, J. Charlet, R.A. Persad, D. Gillatt, J.D. Oxley, and C.D. Nobes. 2010. Competition amongst Eph receptors regulates contact inhibition of locomotion and invasiveness in prostate cancer cells. Nat. Cell Biol. 12:1194-1204. http://dx.doi.org/10.1038/ncb2122
3. Batlle, E., J. Bacani, H. Begthel, S. Jonkheer, A. Gregorieff, M. van de Born, N. Malats, E. Sancho, E. Boon, T. Pawson, et al. 2005. EphB receptor activity suppresses colorectal cancer progression. Nature. 435:1126-1130. http://dx.doi.org/10.1038/nature03626
4. Binns, K.L., P.P. Taylor, F. Sicheri, T. Pawson, and S.J. Holland. 2000. Phosphorylation of tyrosine residues in the kinase domain and juxtamembrane region regulates the biological and catalytic activities of Eph receptors. Mol. Cell. Biol. 20:4791-4805. http://dx.doi.org/10.1128/MCB.20.13.4791-4805.2000
5. Brown, A., P.A. Yates, P. Burrola, D. Ortuño, A. Vaidya, T.M. Jessell, S.L. Pfaff, D.D. O'Leary, and G. Lemke. 2000. Topographic mapping from the retina to the midbrain is controlled by relative but not absolute levels of EphA receptor signaling. Cell. 102:77-88. http://dx.doi.org/10.1016/S0092-8674(00)00012-X
6. Cheng, H.J., M. Nakamoto, A.D. Bergemann, and J.G. Flanagan. 1995. Complementary gradients in expression and binding of ELF-1 and Mek4 in development of the topographic retinotectal projection map. Cell. 82:371-381. http://dx.doi.org/10.1016/0092-8674(95)90426-3
7. Clevers, H., and E. Batlle. 2006. EphB/EphrinB receptors and Wnt signaling in colorectal cancer. Cancer Res. 66:2-5. http://dx.doi.org/10.1158/0008-5472.CAN-05-3849
8. Compagni, A., M. Logan, R. Klein, and R.H. Adams. 2003. Control of skeletal patterning by ephrinB1-EphB interactions. Dev. Cell. 5:217-230. http://dx.doi.org/10.1016/S1534-5807(03)00198-9
9. Cortina, C., S. Palomo-Ponce, M. Iglesias, J.L. Fernández-Masip, A. Vivancos, G. Whissell, M. Humà, N. Peiró, L. Gallego, S. Jonkheer, et al. 2007. EphB-ephrin-B interactions suppress colorectal cancer progression by compartmentalizing tumor cells. Nat. Genet. 39:1376-1383. http://dx.doi.org/10.1038/ng.2007.11
10. Davis, S., N.W. Gale, T.H. Aldrich, P.C. Maisonpierre, V. Lhotak, T. Pawson, M. Goldfarb, and G.D. Yancopoulos. 1994. Ligands for EPH-related receptor tyrosine kinases that require membrane attachment or clustering for activity. Science. 266:816-819. http://dx.doi.org/10.1126/science.7973638
11. Davy, A., and P. Soriano. 2005. Ephrin signaling in vivo: Look both ways. Dev. Dyn. 232:1-10. http://dx.doi.org/10.1002/dvdy.20200
12. Ding, L., G. Getz, D.A. Wheeler, E.R. Mardis, M.D. McLellan, K. Cibulskis, C. Sougnez, H. Greulich, D.M. Muzny, M.B. Morgan, et al. 2008. Somatic mutations affect key pathways in lung adenocarcinoma. Nature. 455:1069-1075. http://dx.doi.org/10.1038/nature07423
13. Dottori, M., M. Down, A. Hüttmann, D.R. Fitzpatrick, and A.W. Boyd. 1999. Cloning and characterization of EphA3 (Hek) gene promoter: DNA methylation regulates expression in hematopoietic tumor cells. Blood. 94:2477-2486.
14. Egea, J., and R. Klein. 2007. Bidirectional Eph-ephrin signaling during axon guidance. Trends Cell Biol. 17:230-238. http://dx.doi.org/10.1016/j.tcb.2007.03.004
15. Flanagan, J.G. 2006. Neural map specification by gradients. Curr. Opin. Neurobiol. 16:59-66. http://dx.doi.org/10.1016/j.conb.2006.01.010
16. Freywald, A., N. Sharfe, and C.M. Roifman. 2002. The kinase-null EphB6 receptor undergoes transphosphorylation in a complex with EphB1. J. Biol. Chem. 277:3823-3828. http://dx.doi.org/10.1074/jbc.M108011200
17. Gale, N.W., S.J. Holland, D.M. Valenzuela, A. Flenniken, L. Pan, T.E. Ryan, M. Henkemeyer, K. Strebhardt, H. Hirai, D.G. Wilkinson, et al. 1996. Eph receptors and ligands comprise two major specificity subclasses and are reciprocally compartmentalized during embryogenesis. Neuron. 17:9-19. http://dx.doi.org/10.1016/S0896-6273(00)80276-7
18. Gu, C., and S. Park. 2001. The EphA8 receptor regulates integrin activity through p110gamma phosphatidylinositol-3 kinase in a tyrosine kinase activityindependent manner. Mol. Cell. Biol. 21:4579-4597. http://dx.doi.org/10.1128/MCB.21.14.4579-4597.2001
19. Hafner, C., G. Schmitz, S. Meyer, F. Bataille, P. Hau, T. Langmann, W. Dietmaier, M. Landthaler, and T. Vogt. 2004. Differential gene expression of Eph receptors and ephrins in benign human tissues and cancers. Clin. Chem. 50:490-499. http://dx.doi.org/10.1373/clinchem.2003.026849
20. Hafner, C., B. Becker, M. Landthaler, and T. Vogt. 2006. Expression profile of Eph receptors and ephrin ligands in human skin and downregulation of EphA1 in nonmelanoma skin cancer. Mod. Pathol. 19:1369-1377. http://dx.doi.org/10.1038/modpathol.3800660
21. Herath, N.I., M.D. Spanevello, S. Sabesan, T. Newton, M. Cummings, S. Duffy, D. Lincoln, G. Boyle, P.G. Parsons, and A.W. Boyd. 2006. Overexpression of Eph and ephrin genes in advanced ovarian cancer: Ephrin gene expression correlates with shortened survival. BMC Cancer. 6:144. http://dx.doi.org/10.1186/1471-2407-6-144
22. Himanen, J.P., M.J. Chumley, M. Lackmann, C. Li, W.A. Barton, P.D. Jeffrey, C. Vearing, D. Geleick, D.A. Feldheim, A.W. Boyd, et al. 2004. Repelling class discrimination: Ephrin-A5 binds to and activates EphB2 receptor signaling. Nat. Neurosci. 7:501-509. http://dx.doi.org/10.1038/nn1237
23. Himanen, J.P., L. Yermekbayeva, P.W. Janes, J.R. Walker, K. Xu, L. Atapattu, K.R. Rajashankar, A. Mensinga, M. Lackmann, D.B. Nikolov, and S. Dhe-Paganon. 2010. Architecture of Eph receptor clusters. Proc. Natl. Acad. Sci. USA. 107:10860-10865. http://dx.doi.org/10.1073/pnas.1004148107
24. Holmberg, J., and J. Frisén. 2002. Ephrins are not only unattractive. Trends Neurosci. 25:239-243. http://dx.doi.org/10.1016/S0166-2236(02)02149-5
25. Holmberg, J., D.L. Clarke, and J. Frisén. 2000. Regulation of repulsion versus adhesion by different splice forms of an Eph receptor. Nature. 408:203-206. http://dx.doi.org/10.1038/35041577
26. Howarth, M., and A.Y. Ting. 2008. Imaging proteins in live mammalian cells with biotin ligase and monovalent streptavidin. Nat. Protoc. 3:534-545. http://dx.doi.org/10.1038/nprot.2008.20
27. Howarth, M., K. Takao, Y. Hayashi, and A.Y. Ting. 2005. Targeting quantum dots to surface proteins in living cells with biotin ligase. Proc. Natl. Acad. Sci. USA. 102:7583-7588. http://dx.doi.org/10.1073/pnas.0503125102
28. Huusko, P., D. Ponciano-Jackson, M. Wolf, J.A. Kiefer, D.O. Azorsa, S. Tuzmen, D. Weaver, C. Robbins, T. Moses, M. Allinen, et al. 2004. Nonsense-mediated decay microarray analysis identifies mutations of EPHB2 in human prostate cancer. Nat. Genet. 36:979-983. http://dx.doi.org/10.1038/ng1408
29. Janes, P.W., N. Saha, W.A. Barton, M.V. Kolev, S.H. Wimmer-Kleikamp, E. Nievergall, C.P. Blobel, J.P. Himanen, M. Lackmann, and D.B. Nikolov. 2005. Adam meets Eph: An ADAM substrate recognition module acts as a molecular switch for ephrin cleavage in trans. Cell. 123:291-304. http://dx.doi.org/10.1016/j.cell.2005.08.014
30. Janes, P.W., S. Adikari, and M. Lackmann. 2008. Eph/ephrin signalling and function in oncogenesis: Lessons from embryonic development. Curr. Cancer Drug Targets. 8:473-479. http://dx.doi.org/10.2174/156800908785699315
31. Janes, P.W., S.H. Wimmer-Kleikamp, A.S. Frangakis, K. Treble, B. Griesshaber, O. Sabet, M. Grabenbauer, A.Y. Ting, P. Saftig, P.I. Bastiaens, and M. Lackmann. 2009. Cytoplasmic relaxation of active Eph controls ephrin shedding by ADAM10. PLoS Biol. 7:e1000215. http://dx.doi.org/10.1371/journal.pbio.1000215
32. Jares-Erijman, E.A., and T.M. Jovin. 2003. FRET imaging. Nat. Biotechnol. 21:1387-1395. http://dx.doi.org/10.1038/nbt896
33. Jørgensen, C., A. Sherman, G.I. Chen, A. Pasculescu, A. Poliakov, M. Hsiung, B. Larsen, D.G. Wilkinson, R. Linding, and T. Pawson. 2009. Cellspecific information processing in segregating populations of Eph receptor ephrin-expressing cells. Science. 326:1502-1509. http://dx.doi.org/10.1126/science.1176615
34. Klein, R. 2004. Eph/ephrin signaling in morphogenesis, neural development and plasticity. Curr. Opin. Cell Biol. 16:580-589. http://dx.doi.org/10.1016/j.ceb.2004.07.002
35. Koolpe, M., R. Burgess, M. Dail, and E.B. Pasquale. 2005. EphB receptor-binding peptides identified by phage display enable design of an antagonist with ephrin-like affinity. J. Biol. Chem. 280:17301-17311. http://dx.doi.org/10.1074/jbc.M500363200
36. Lackmann, M., and A.W. Boyd. 2008. Eph, a protein family coming of age: More confusion, insight, or complexity? Sci. Signal. 1:re2. http://dx.doi.org/10.1126/stke.115re2
37. Lackmann, M., R.J. Mann, L. Kravets, F.M. Smith, T.A. Bucci, K.F. Maxwell, G.J. Howlett, J.E. Olsson, T. Vanden Bos, D.P. Cerretti, and A.W. Boyd. 1997. Ligand for EPH-related kinase (LERK) 7 is the preferred high affinity ligand for the HEK receptor. J. Biol. Chem. 272:16521-16530. http://dx.doi.org/10.1074/jbc.272.26.16521
38. Lackmann, M., A.C. Oates, M. Dottori, F.M. Smith, C. Do, M. Power, L. Kravets, and A.W. Boyd. 1998. Distinct subdomains of the EphA3 receptor mediate ligand binding and receptor dimerization. J. Biol. Chem. 273:20228-20237. http://dx.doi.org/10.1074/jbc.273.32.20228
39. Lawrenson, I.D., S.H. Wimmer-Kleikamp, P. Lock, S.M. Schoenwaelder, M. Down, A.W. Boyd, P.F. Alewood, and M. Lackmann. 2002. Ephrin-A5 induces rounding, blebbing and de-adhesion of EphA3-expressing 293T and melanoma cells by CrkII and Rho-mediated signalling. J. Cell Sci. 115:1059-1072.
40. Lemke, G., and M. Reber. 2005. Retinotectal mapping: New insights from molecular genetics. Annu. Rev. Cell Dev. Biol. 21:551-580. http://dx.doi.org/10.1146/annurev.cellbio.20.022403.093702
41. Marquardt, T., R. Shirasaki, S. Ghosh, S.E. Andrews, N. Carter, T. Hunter, and S.L. Pfaff. 2005. Coexpressed EphA receptors and ephrin-A ligands mediate opposing actions on growth cone navigation from distinct membrane domains. Cell. 121:127-139. http://dx.doi.org/10.1016/j.cell.2005.01.020
42. Matsuoka, H., H. Obama, M.L. Kelly, T. Matsui, and M. Nakamoto. 2005. Biphasic functions of the kinase-defective Ephb6 receptor in cell adhesion and migration. J. Biol. Chem. 280:29355-29363. http://dx.doi.org/10.1074/jbc.M500010200
43. McLaughlin, T., and D.D. O'Leary. 2005. Molecular gradients and development of retinotopic maps. Annu. Rev. Neurosci. 28:327-355. http://dx.doi.org/10.1146/annurev.neuro.28.061604.135714
44. Mellitzer, G., Q. Xu, and D.G. Wilkinson. 1999. Eph receptors and ephrins restrict cell intermingling and communication. Nature. 400:77-81. http://dx.doi.org/10.1038/21907
45. Nievergall, E., P.W. Janes, C. Stegmayer, M.E. Vail, F.G. Haj, S.W. Teng, B.G. Neel, P.I. Bastiaens, and M. Lackmann. 2010. PTP1B regulates Eph receptor function and trafficking. J. Cell Biol. 191:1189-1203. http://dx.doi.org/10.1083/jcb.201005035
46. Noren, N.K., G. Foos, C.A. Hauser, and E.B. Pasquale. 2006. The EphB4 receptor suppresses breast cancer cell tumorigenicity through an Abl-Crk pathway. Nat. Cell Biol. 8:815-825. http://dx.doi.org/10.1038/ncb1438
47. Noren, N.K., N.Y. Yang, M. Silldorff, R. Mutyala, and E.B. Pasquale. 2009. Ephrin-independent regulation of cell substrate adhesion by the EphB4 receptor. Biochem. J. 422:433-442. http://dx.doi.org/10.1042/BJ20090014
48. Pasquale, E.B. 2004. Eph-ephrin promiscuity is now crystal clear. Nat. Neurosci. 7:417-418. http://dx.doi.org/10.1038/nn0504-417
49. Pasquale, E.B. 2005. Eph receptor signalling casts a wide net on cell behaviour. Nat. Rev. Mol. Cell Biol. 6:462-475. http://dx.doi.org/10.1038/nrm1662
50. Pasquale, E.B. 2010. Eph receptors and ephrins in cancer: Bidirectional signalling and beyond. Nat. Rev. Cancer. 10:165-180. http://dx.doi.org/10.1038/nrc2806
51. Poliakov, A., M.L. Cotrina, A. Pasini, and D.G. Wilkinson. 2008. Regulation of EphB2 activation and cell repulsion by feedback control of the MAPK pathway. J. Cell Biol. 183:933-947. http://dx.doi.org/10.1083/jcb.200807151
52. Reber, M., P. Burrola, and G. Lemke. 2004. A relative signalling model for the formation of a topographic neural map. Nature. 431:847-853. http://dx.doi.org/10.1038/nature02957
53. Salaita, K., P.M. Nair, R.S. Petit, R.M. Neve, D. Das, J.W. Gray, and J.T. Groves. 2010. Restriction of receptor movement alters cellular response: Physical force sensing by EphA2. Science. 327:1380-1385. http://dx.doi.org/10.1126/science.1181729
54. Seiradake, E., K. Harlos, G. Sutton, A.R. Aricescu, and E.Y. Jones. 2010. An extracellular steric seeding mechanism for Eph-ephrin signaling platform assembly. Nat. Struct. Mol. Biol. 17:398-402. http://dx.doi.org/10.1038/nsmb.1782
55. Sjöblom, T., S. Jones, L.D. Wood, D.W. Parsons, J. Lin, T.D. Barber, D. Mandelker, R.J. Leary, J. Ptak, N. Silliman, et al. 2006. The consensus coding sequences of human breast and colorectal cancers. Science. 314:268-274. http://dx.doi.org/10.1126/science.1133427
56. Smith, F.M., C. Vearing, M. Lackmann, H. Treutlein, J. Himanen, K. Chen, A. Saul, D. Nikolov, and A.W. Boyd. 2004. Dissecting the EphA3/Ephrin-A5 interactions using a novel functional mutagenesis screen. J. Biol. Chem. 279:9522-9531. http://dx.doi.org/10.1074/jbc.M309326200
57. Stein, E., A.A. Lane, D.P. Cerretti, H.O. Schoecklmann, A.D. Schroff, R.L. Van Etten, and T.O. Daniel. 1998. Eph receptors discriminate specific ligand oligomers to determine alternative signaling complexes, attachment, and assembly responses. Genes Dev. 12:667-678. http://dx.doi.org/10.1101/gad.12.5.667
58. Taddei, M.L., M. Parri, A. Angelucci, B. Onnis, F. Bianchini, E. Giannoni, G. Raugei, L. Calorini, N. Rucci, A. Teti, et al. 2009. Kinase-dependent and -independent roles of EphA2 in the regulation of prostate cancer invasion and metastasis. Am. J. Pathol. 174:1492-1503. http://dx.doi.org/10.2353/ajpath.2009.080473
59. Tong, J., S. Elowe, P. Nash, and T. Pawson. 2003. Manipulation of EphB2 regulatory motifs and SH2 binding sites switches MAPK signaling and biological activity. J. Biol. Chem. 278:6111-6119. http://dx.doi.org/10.1074/jbc.M208972200
60. Vearing, C., F.T. Lee, S. Wimmer-Kleikamp, V. Spirkoska, C. To, C. Stylianou, M. Spanevello, M. Brechbiel, A.W. Boyd, A.M. Scott, and M. Lackmann. 2005. Concurrent binding of anti-EphA3 antibody and ephrin-A5 amplifies EphA3 signaling and downstream responses: Potential as EphA3-specific tumor-targeting reagents. Cancer Res. 65:6745-6754. http://dx.doi.org/10.1158/0008-5472.CAN-05-0758
61. Verveer, P.J., A. Squire, and P.I. Bastiaens. 2000. Global analysis of fluorescence lifetime imaging microscopy data. Biophys. J. 78:2127-2137. http://dx.doi.org/10.1016/S0006-3495(00)76759-2
62. Wimmer-Kleikamp, S.H., P.W. Janes, A. Squire, P.I.H. Bastiaens, and M. Lackmann. 2004. Recruitment of Eph receptors into signaling clusters does not require ephrin contact. J. Cell Biol. 164:661-666. http://dx.doi.org/10.1083/jcb.200312001
63. Wouters, F.S., P.J. Verveer, and P.I. Bastiaens. 2001. Imaging biochemistry inside cells. Trends Cell Biol. 11:203-211. http://dx.doi.org/10.1016/S0962-8924(01)01982-1
64. Wybenga-Groot, L.E., B. Baskin, S.H. Ong, J. Tong, T. Pawson, and F. Sicheri. 2001. Structural basis for autoinhibition of the Ephb2 receptor tyrosine kinase by the unphosphorylated juxtamembrane region. Cell. 106:745-757. http://dx.doi.org/10.1016/S0092-8674(01)00496-2
65. Xu, Q., G. Mellitzer, and D.G. Wilkinson. 2000. Roles of Eph receptors and ephrins in segmental patterning. Philos. Trans. R. Soc. Lond. B Biol. Sci. 355:993-1002. http://dx.doi.org/10.1098/rstb.2000.0635